EVEREST MED

Forecast & Rating6 analysts currently cover EVEREST MED, with about 50.0% giving a positive rating — meaning they expect the stock to rise. The average price target is HK$42.22, about 67.9% upside from the current price of HK$25.14. Price targets range from HK$25.61 to HK$69.11 — a wide spread, showing clear disagreement over just how much EVEREST MED can rise. Historically, about 59.1% of past price targets were eventually met, which adds credibility. For you, this means institutional views on EVEREST MED are split — bulls and bears coexist, so you'll need to weigh it against your own judgment. Data as of Jul 29, 2026; for reference only and not investment advice.